Psilocybin 25 mg Clinical Trials
7 recruitingDrug
Phase 25Early Phase 12
Showing 1–7 of 7 trials
Recruiting
Phase 2
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Post Traumatic Stress DisorderPTSD
Sunstone Medical70 enrolled1 locationNCT06902974
Recruiting
Early Phase 1
Psilocybin for Prolonged Grief Disorder
Prolonged grief disorder
University of Virginia12 enrolled1 locationNCT06724289
Recruiting
Early Phase 1
Psilocybin for Methamphetamine Addiction
Methamphetamine Use Disorder
Kevin Murnane20 enrolled1 locationNCT06899594
Recruiting
Phase 2
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
PTSDAlcohol Use Disorder (AUD)
Nathan Brashares Sackett40 enrolled1 locationNCT06853912
Recruiting
Phase 2
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
Treatment Resistant Depression
Centre for Addiction and Mental Health12 enrolled1 locationNCT06512220
Recruiting
Phase 2
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
Chronic PainTreatment Resistant Depression
Centre for Addiction and Mental Health16 enrolled1 locationNCT06518720
Recruiting
Phase 2
Does Psilocybin Require Psychedelic Effects to Treat Depression?
Treatment Resistant Depression
Centre for Addiction and Mental Health60 enrolled1 locationNCT05710237